Merck reported positive results for its experimental treatment designed to protect infants from RSV. The mid to late-stage ...

Through experiments on mice infected with a herpes virus, scientists discovered an immune system sensor that detects viral ...

Authorities in Hyderabad uncover a quack's illegal steroid operation, raising alarms over rampant steroid abuse and serious ...

According to the CDC, respiratory infections caused by the bacteria Mycoplasma pneumoniae have increased in the U.S. over the ...

Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...

This month, Sentara Health and Macon & Joan Brock Virginia Health Sciences at Old Dominion University launched the ...

A 54-year old UAE resident nearly went blind recently following a severe corneal infection that worsened post-eye surgery.

Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

Read more on CorMedix (CRMD)'s FDA-approved DefenCath and its potential in the CRBSI market, but be cautious of stock spikes ...

The drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.

Meanwhile, some people might notice they can no longer tolerate the cold—which is one sign of hypothyroidism, or an ...

The California Department of Public Health reported a total of 13 human bird flu cases have been confirmed in California as ...